Abstracts

DISTINCT CORD C-PEPTIDE, ADIPOKINE, AND LIPIDOMIC SIGNATURES BY IN UTERO HIV EXPOSURE

Metabolic derangements early in life of HIV-exposed uninfected (HEU) infants have been reported. Pregnant HIV+ and HIV- women were enrolled with their infants in a US cohort from 2009-15. We measured insulin, C-peptide, and adipokines [metabolic (resistin, leptin) and inflammatory (Interleukin (IL)-6, Tumor Necrosis Factor-a (TNFa)] in cord blood of HEU and HIV-unexposed uninfected (HUU) infants using multiplex ELISA. Demographic,…

REDUCED BASAL GANGLIA AND TOTAL GREY MATTER VOLUME IN HIV-EXPOSED UNINFECTED NEONATES

Evidence suggests HIV-exposed uninfected (HEU) children have impaired early growth and development compared to HIV-unexposed (HU) children. However, little is known about the neurobiological mechanisms underlying adverse developmental outcomes in this population. We examined the effects of in utero exposure to HIV and ART on the neuroanatomy of uninfected neonates in a South African birth…

POSTNATAL LPV/R EXPOSURE, GROWTH, AND NEUROPSYCHOLOGICAL OUTCOMES AT SCHOOL AGE

In the ANRS 12174 randomized controlled trial, HIV-exposed uninfected African neonates who received lopinavir-ritonavir (LPV/r) prophylaxis for one year exhibited slower growth from birth to week 50 compared with those receiving lamivudine (3TC). We assessed whether this difference in growth persisted over time, and was accompanied by differences in neuropsychological and clinical outcomes. Between February…

BREASTMILK MICROBIOME/VIROME OF HIV+ KENYAN WOMEN IS NOT ALTERED BY IMMUNOSUPPRESSION

Breast milk (BM) harbors a diverse community of bacteria (microbiome) and viruses (virome) that are transmitted from mother-to-infant during breastfeeding and are important for establishing a healthy infant gut flora. Whether the BM microbiome and virome of women living with HIV are altered by immunosuppression and influence morbidity in HIV-exposed infants are unknown. We hypothesized…

METABOLITES, PRETERM LABOR, AND ANTIRETROVIRAL THERAPY

Antiretroviral treatment (ART) has significantly reduced AIDS-related deaths, however, ART, including protease inhibitors, has been associated with an increased risk of preterm birth (PTB). In PROMISE, PTB (<37 weeks) occurred in 20.5% of pregnancies where mothers received zidovudine, lamivudine, lopinavir-ritonavir (PI) versus 13.1% where mothers received zidovudine alone (ZDV), p<0.001.  To date the mechanisms involved in…

MATERNAL BIOMARKERS OF ENDOTHELIAL DYSFUNCTION BY HIV/ART STATUS AND BIRTH OUTCOMES

Women living with HIV (WLHIV) are at higher risk of having an adverse birth outcomes, with underlying mechanism(s) unknown. We hypothesized that HIV-associated endothelial activation could adversely impact placental function and lead to impaired fetal growth or stillbirth. We used previously-collected data and samples from WLHIV and HIV-negative women enrolled during pregnancy in the observational…

MATERNAL AND CORD PLASMA BIOACTIVE EICOSANOID PROFILES DIFFER IN HIV+ AND HIV– WOMEN

Pregnant women with HIV (WHIV) are more likely to experience adverse birth outcomes, through mechanisms not fully understood. Eicosanoids play important roles in pregnancy and fetal growth and development, but data are lacking in the context of pregnancy, HIV, and antiretroviral therapy (ART). We examined bioactive eicosanoids (cell-signaling molecules derived from polyunsaturated fatty acids) in…